Clinical application of O-RADS combined with CEUS and HE4 in the diagnosis of adnexal masses
Medical Ultrasonography · 2025
DOI: 10.11152/mu-4573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Ultrasonography, 2025. Verfasst von Qian Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center,Southern Medical University, Shenzhe…. Hauptthemen laut MEDLINE: Adnexal Diseases, Contrast Media, WAP Four-Disulfide Core Domain Protein 2.
Abstract (Originalsprache)
Aim
This study aimed to evaluate the diagnostic value of combining Ovarian-Adnexal Reporting and Data System (O-RADS), contrast-enhanced ultrasound (CEUS) scoring, and serum human epididymis protein 4 (HE4) in differentiating benign and malignant adnexal masses.Material and methods: A retrospective analysis was performed on 41 surgically resected adnexal masses confirmed by pathology between May 2022 and July 2025. All patients underwent routine ultrasound, CEUS, and preoperative serum HE4 testing. Adnexal masses were classified using O-RADS and assessed with three CEUS qualitative scores (initial enhancement time, enhancement intensity, and washout pattern) alongside HE4 levels.
Results
O-RADS alone showed a sensitivity of 69.2% for borderline and malignant adnexal masses (AUC 0.794). Adding CEUS increased sensitivity to 88.5% (AUC 0.906), and including HE4 further raised it to 96.2% (AUC 0.947). CEUS parameters differed significantly between benign and malignant adnexal masses (p < 0.001). The combined model markedly improved classification of intermediate-risk adnexal masses and reduced misclassification. Interobserver agreement was excellent (Kappa >0.85).
Conclusion
The integration of O-RADS with CEUS scoring and HE4 testing significantly improves the diagnostic accuracy for adnexal masses. This improvement is particularly notable in intermediate-risk adnexal masses. Our findings support the clinical utility of this integrated approach for risk stratification and decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center,Southern Medical University, Shenzhen, Guangdong Province.
- Department of Ultrasound, Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center,Southern Medical University, Shenzhen, Guangdong Province. yying0624@163.com.
- Department of Gynecology Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center, Southern Medical University, Shenzhen.
Zitieren
APA
Fu, Q., Yuan, Y., Zhou, Z., Huang, Y., Lin, Y., Ouyang, D., & Shi, W. (2025). Clinical application of O-RADS combined with CEUS and HE4 in the diagnosis of adnexal masses. Medical Ultrasonography. https://doi.org/10.11152/mu-4573
Vancouver
Fu Q, Yuan Y, Zhou Z, Huang Y, Lin Y, Ouyang D, et al. Clinical application of O-RADS combined with CEUS and HE4 in the diagnosis of adnexal masses. Medical Ultrasonography. 2025. doi:10.11152/mu-4573
BibTeX
@article{Fu2025,
author = {Fu, Qian and Yuan, Ying and Zhou, Zhaohui and Huang, Yi and Lin, Yan and Ouyang, Duanyuan and Shi, Wenjuan},
title = {Clinical application of O-RADS combined with CEUS and HE4 in the diagnosis of adnexal masses},
journal = {Medical Ultrasonography},
year = {2025},
doi = {10.11152/mu-4573}
}
EUVIMED